To test this, we treated four common melanoma cell lines (LOX-IMVI, SK-MEL-5, UACC62 and UACC257) with DNA-damaging agents (UV and etoposide) or the non-genotoxic MDM2 inhibitor and p53 activator Nutlin-3A [29]. This evidence concerns the gene TP53 and melanoma.